Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$5.04 - $8.6 $5,947 - $10,148
-1,180 Reduced 4.65%
24,220 $125,000
Q4 2022

Feb 13, 2023

BUY
$5.8 - $8.98 $147,320 - $228,092
25,400 New
25,400 $166,000
Q1 2020

May 13, 2020

SELL
$9.31 - $21.24 $218,245 - $497,908
-23,442 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$13.91 - $21.48 $326,078 - $503,534
23,442 New
23,442 $469,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.